US 11053484
Genetically-modified T cells comprising a modified intron in the T cell receptor alpha gene
granted A61KA61K40/11A61K40/31
Quick answer
US patent 11053484 (Genetically-modified T cells comprising a modified intron in the T cell receptor alpha gene) held by Precision BioSciences, Inc. expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Precision BioSciences, Inc.
- Grant date
- Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K40/11, A61K40/31, A61K40/32, A61K40/40